FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称TOCILIZUMAB
异名/同义词AVTOZMA
TOCILIZUMAB-ANOH
ACTEMRA
ATLIZUMAB
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MOUSE MONOCLONAL MRA HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL MRA .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 6 RECEPTOR) (HUMAN-MOUSE MONOCLONAL MRA HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MRA .KAPPA.-CHAIN, DIMER
MRA
R-1569
RG-1569
RHPM-1
RO-4877533
ROACTEMRA
TOCILIZUMAB (GENETICAL RECOMBINATION)
TOCILIZUMAB [EMA EPAR]
TOCILIZUMAB [JAN]
TOCILIZUMAB [MART.]
TOCILIZUMAB [MI]
TOCILIZUMAB [PURPLE BOOK CDER]
TOCILIZUMAB [USAN]
TOCILIZUMAB [VANDF]
TOCILIZUMAB
TOCILIZUMAB [WHO-DD]
TOCILIZUMAB [INN]
RGB-19
RGB19
BIIB-800
BIIB800
TOFIDENCE
TOCILIZUMAB-BAVI
MSB-11456
MSB11456
TOCILIZUMAB BIOSIMILAR (MSB11456)
TYENNE
TOCILIZUMAB-AAZG
TOCILIZUMAB BIOSIMILAR (RGB-19)
BAT-1806
BAT1806
TOCILIZUMAB BIOSIMILAR (BAT-1806)
CAS登记号375823-41-9
物质唯一标识(Unique Ingredient Identifier)I031V2H011
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System